Biologic and Epidemiologic Markers of Endometriosis (BEME)

What is the Purpose of this Study?

The purpose of this study is to identify biomarkers of benign gynecologic conditions, with a particular focus on endometriosis. In endometriosis, uterus-like tissue grows in other parts of the body. Biomarkers are molecules found in blood, body fluids, and tissues that can be a sign of a normal or abnormal process of a disease. Endometriosis is difficult to diagnose because symptoms are non-specific and varied; some women may not even show symptoms. The study aims to understand patient lifestyle factors, outcomes and experiences of pain and infertility associated with the disease. In so doing, researchers hope to develop novel ways to diagnose endometriosis without the need for surgery. Participants will be asked to complete questionnaires about their reproductive health and history. Researchers will also collect biological specimens (such as tissue and blood), and medical records will be reviewed.


Eligibility

Not Available


Where can I participate?

  • Beverly
  • Cedars-Sinai Cancer at SOCC



What is the full name of this clinical trial?

Biologic and Epidemiologic Markers of Endometriosis

Study Details
Disease Type/Condition

Other

Principal Investigator

Lawrenson, Kate

Co-Investigators

Marc Goodman

Age Group

Adult

Phase

N/A

IRB Number

STUDY00000063


How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Other

Principal Investigator

Lawrenson, Kate

Age Group

Adult

Phase

N/A

IRB Number

BB-STUDY00000063


Contact
Email
clinicaltrials@cshs.org